- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD) in United States
Total 675 results
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
National Institute of Diabetes and Digestive and...CompletedFatty Liver | Nonalcoholic SteatohepatitisUnited States
-
Johns Hopkins UniversityResMed FoundationCompletedObstructive Sleep Apnea | Non Alcoholic Fatty Liver DiseaseUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
Terns, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Natalie TorokActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
University of Missouri-ColumbiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American...CompletedObesity, Morbid | Bariatric Surgery Candidate | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Massachusetts General HospitalCompletedObesity | Fatty Liver, NonalcoholicUnited States
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
National Institute of Diabetes and Digestive and...Completed
-
Zydus Therapeutics Inc.RecruitingNonalcoholic SteatohepatitisUnited States
-
St. Louis UniversityHoffmann-La RocheCompletedHepatitis | Fatty LiverUnited States
-
Madrigal Pharmaceuticals, Inc.CompletedHepatic Impairment | NASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
University of Texas Southwestern Medical CenterCompletedObesity | Metabolic Syndrome | Non-alcoholic Fatty Liver DiseaseUnited States
-
National Institute of Diabetes and Digestive and...Completed
-
Zydus Therapeutics Inc.RecruitingFibrosis | Nonalcoholic SteatohepatitisUnited States, Turkey, Argentina
-
Yale UniversityAmerican Heart AssociationTerminatedNon Alcoholic Fatty Liver DiseaseUnited States
-
Tobira Therapeutics, Inc.TerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Australia, France, Germany, Spain, Poland, United Kingdom, Italy, Puerto Rico, Belgium, Hong Kong
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Viking Therapeutics, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
University of MichiganNational Institutes of Health (NIH)CompletedNon-alcoholic Fatty Liver Disease | Morbid ObesityUnited States
-
University of California, San DiegoCompletedHIV | Nonalcoholic Fatty Liver DiseaseUnited States
-
AstraZenecaAstraZeneca K.K.RecruitingNonalcoholic SteatohepatitisUnited States, China, Korea, Republic of, Germany, Japan, Spain, Vietnam, Argentina, Colombia, Peru, Brazil, Malaysia, Taiwan, Thailand, Italy, Turkey, Hong Kong, Singapore, India, Mexico, Chile, Philippines, Portugal
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
King's College Hospital NHS TrustSamsung MedisonRecruitingHepatitis | Liver Fat | NAFLD | Fibrosis, Liver | Liver Disease Chronic | Liver Steatoses | NASH With FibrosisUnited Kingdom
-
NGM Biopharmaceuticals, IncCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Australia, Belgium, France, Germany, Hong Kong, Poland, Puerto Rico, United Kingdom
-
Galmed Research and Development, Ltd.SuspendedNonalcoholic Steatohepatitis (NASH)United States
-
Sheffield Teaching Hospitals NHS Foundation TrustBayerCompletedHypogonadism | Nonalcoholic SteatohepatitisUnited Kingdom
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more
-
Forma Therapeutics, Inc.ProSciento, Inc.TerminatedNonalcoholic Steatohepatitis (NASH) | Overweight or ObesityUnited States
-
University of California, DavisCompletedMetabolic Syndrome | Nonalcoholic SteatohepatitisUnited States
-
Boehringer IngelheimRecruitingObesity | Non-alcoholic Fatty Liver DiseaseUnited States
-
University of BirminghamNovo Nordisk A/S; Wellcome TrustCompletedNonalcoholic SteatohepatitisUnited Kingdom
-
Boston PharmaceuticalsActive, not recruitingNonalcoholic Steatohepatitis (NASH)United States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedNonalcoholic Steatohepatitis | Lipodystrophy | Fatty Liver Disease, NonalcoholicUnited States
-
Intercept PharmaceuticalsCompletedNonalcoholic Steatohepatitis | Compensated CirrhosisUnited States, Spain, France, Australia, New Zealand, Puerto Rico, Germany, Canada, United Kingdom, Hungary, Poland, Ukraine
-
Columbia UniversityCompletedInsulin Resistance | Dyslipidemias | HyperinsulinemiaUnited States
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Indiana UniversityRecruitingNASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
Vanderbilt University Medical CenterRecruitingHIV | Non-Alcoholic Fatty Liver Disease | Metabolic-Associated Steatotic Liver DiseaseUnited States
-
Ionis Pharmaceuticals, Inc.CompletedHepatic SteatosisCanada, Hungary, Poland, United Kingdom
-
Intercept PharmaceuticalsCompletedFatty Liver | Diabetes Mellitus, Type IIUnited States
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
University of Alabama at BirminghamCompletedInsulin Resistance | Non-alcoholic Fatty Liver Disease | Childhood ObesityUnited States
-
Columbia UniversityActive, not recruitingPolycystic Ovary Syndrome | Metabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseUnited States